A detailed history of Gs Investments, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Gs Investments, Inc. holds 20,000 shares of INCY stock, worth $1.38 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
20,000
Previous 20,000 -0.0%
Holding current value
$1.38 Million
Previous $1.21 Million 9.08%
% of portfolio
0.59%
Previous 0.57%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022

SELL
$66.02 - $79.71 $841,755 - $1.02 Million
-12,750 Reduced 38.93%
20,000 $1.53 Million
Q2 2021

Aug 05, 2021

BUY
$79.87 - $87.53 $2.4 Million - $2.63 Million
30,000 Added 1090.91%
32,750 $2.76 Million
Q3 2020

Nov 12, 2020

SELL
$85.07 - $109.69 $2.56 Million - $3.3 Million
-30,075 Reduced 91.62%
2,750 $247,000
Q4 2017

Feb 13, 2018

BUY
$93.56 - $116.6 $264,307 - $329,395
2,825 Added 9.42%
32,825 $3.11 Billion
Q2 2017

Aug 29, 2017

BUY
N/A
30,000
30,000 $3.78 Billion

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Gs Investments, Inc. Portfolio

Follow Gs Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gs Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gs Investments, Inc. with notifications on news.